VANCOUVER, BC, Oct. 12, 2021 /CNW/ – Filament Health Corp. (NEO: FH) (OTCQB: FLHLF) (“Filament” or the “Company”), an exclusively-natural psychedelic drug discovery company, today announced its common shares have been approved for uplisting and trading on the OTCQB® Venture Market (“OTCQB”). The Company has also received approval from the Depository Trust Company (“DTC”) to make the Company’s common shares eligible to be electronically cleared and settled through DTC (“DTC Eligibility”).
Effective today, the Company’s common shares are quoted on the OTCQB under the symbol “FLHLF,” and will continue to trade on Canada’s NEO Exchange under its existing symbol “FH.”
The DTC is a subsidiary of the Depository Trust & Clearing Corporation and manages the electronic clearing and settlement of publicly traded companies. DTC eligibility incorporates an electronic method of clearing securities that accelerates the receipt of stock and cash, reduces costs, and allows the stock to be traded over a much wider selection of brokerage firms by meeting their clearing and settlement requirements.
“Listing on the OTCQB and obtaining DTC Eligibility are important milestones towards increasing investor access for a wide range of United States investors and increasing our trading liquidity,” said Chief Financial Officer, Warren Duncan. “With these announcements, we look forward to expanding Filament’s presence in the U.S. and deepening our relationships with our investor base, furthering our mission to get safe, natural psychedelics into the hands of everyone who needs them as soon as possible.”
ABOUT OTC MARKETS GROUP INC.
OTC Markets Group Inc. operates the OTCQX® Best Market, the OTCQB® Venture Market and the Pink® Open Market for 11,000 U.S. and global securities. Through OTC Link® ATS and OTC Link ECN, PTC Market Group Inc. connects a diverse network of broker-dealers that provide liquidity and execution services. The company enables investors to easily trade through the broker of their choice and empower companies to improve the quality of information available for investors. To learn more about how OTC Markets Group Inc. creates better informed and more efficient markets, visit www.otcmarkets.com.
ABOUT FILAMENT HEALTH
Filament is an exclusively-natural psychedelic drug discovery and extraction technology company. Its mission is to see safe, approved, natural psychedelics in the hands of everyone who needs them as soon as possible. Filament believes measurable and efficacious medicines will be a catalyst to addressing many of the world’s mental health problems and that natural psychedelics provide an optimal option for widespread adoption of these substances. Filament engages in natural extraction technology commercialization, utilizing its intellectual property portfolio, in-house GMP facility, and Health Canada Dealer’s License for…